QuickStart, in partnership with the Ottawa Children's Treatment Centre (OCTC), provides early intervention for children prior to a formal diagnosis of autism.
Since the launch of their Getting Started Services in October 2007, children receive help and support as soon as their parents become concerned.
Getting Started Services provides preliminary screening of your child, followed by one-on-one appointments with a professional who will teach
and demonstrate strategies to help you work with your child. Tips, guides and resources are presented onsite. QuickStart also recommends thimerosal-free vaccines
and spreading out the vaccinations your child receives.
Free program for ages six and under, designed to help
meet the needs of families of children with autism (a formal
diagnosis of autism is not necessary).
The robot Keepon (developed by Hideki Kozima and programmed by Marek Michalowski) dances to the song "I Turn My Camera On" by the band Spoon. (27.03.07)
Two years ago, a yellow spongiform robot named Keepon became a minor YouTube sensation when one of its creators programmed it to do a squishy, twisty dance in time to the Spoon
song "I Turn My Camera On." The video has garnered more than 2 million hits. Now Keepon's keepers, Marek Michalowski, a Ph.D student in robotics at Carnegie Mellon University,
and Hideki Kozima of Miyagi University in Japan, are turning Keepon's attention to a more serious task: to study how children with autism spectrum disorders (ASD) interact
socially and to see if the robot may be able to help in therapy.
Keepon is just one of the many new robots that researchers are using to study and to help children with ASD. The robots do everything from studying the children's social
interactions and their emotional states to drawing them out socially.
Children with ASD often have trouble with the "dance" of body language and facial gestures needed to have successful conversations and social contact with others. Both
reading the intentions of others and knowing their own emotions can be a struggle, and children often become stranded both emotionally and socially.
One baby in every 150 born today in the U.S. is diagnosed with ASD. Treatment involves a combination of therapies -- behavioral, educational, physical, occupational,
and speech -- that is costly and not always effective. After finding that children with ASD interact more easily with robots than with people, researchers began developing
expressive and interactive robots that can assist them in studying and creating effective therapy for the children.
Keepon's gentle boogieing and its simple, innocuous appearance (five inches tall, rubbery, resembling two tennis balls stacked one on top of the other) make it
perfect for interacting with socially withdrawn children. Armless and legless and only possessing two eyes and a nose, Keepon expresses itself mainly through
its four movements: nodding, turning, rocking and bobbing.
However, Keepon does have a camera behind those eyes and a microphone hidden in its nose. Researchers Michalowski and Kozima have studied preschool children with
ASD in Japan and have found that interacting with the robots draws the children into a range of new social behaviors. Videos of those encounters show the children
feeding Keepon imaginary food, giving it imaginary medicine when it has a Band-Aid on its head, and protecting it against abuse by other children.
Keepon is designed to interact with children by communicating attention
and emotion in the simplest and most comprehensible way. (12.08.07)
The most striking video shows one girl slowly forging a relationship with the robot. At first she refuses to even directly look at Keepon, but as the days go on, she
draws closer to the robot, eventually touching it with a xylophone stick, then her hand. After weeks, she can be seen looking into Keepon's eyes, putting a hat on it,
and even giving it a kiss, an action she rarely performed even towards her own mother. [...] [Read More]
Keepon dances to the Spoon song "Don't You Evah." Directed by Jeff Nichols and produced by WIRED Magazine.
(4 May 2008)
Last Updated: 28 December 2011
Autism & Neurodevelopmental Disorders Causative Factors, Early Detection, and Interventions:
Notes and References
This page presents selected notes, references and resources regarding the causation, diagnosis and treatment of autism and neurodevelopmental disorders
in childhood. Thimerosal, vaccines contaminated by human DNA, immunization schedules, toxic chemical exposure, biomedical problems and genetic factors are considered, as well as
dietary and nutritional strategies, novel interventions, early detection and support services in the Ottawa region and elsewhere. Selected clinical studies and reviews are
provided with respect to the neurodevelopmental impact of mercury and other heavy metals.
Three new studies conclude that autism disorders are genetically very complex, not caused by one or two gene defects. The potential changes in DNA may produce what are essentially different forms of autism.
Autism is not caused by one or two gene defects but probably by hundreds of different mutations, many of which arise spontaneously, according to research that examined the genetic underpinnings of the disorder in more
than 1,000 families.
The findings, reported in three studies published Wednesday in the journal Neuron, cast autism disorders as genetically very complex, involving many potential changes in DNA that may produce, essentially, different
forms of autism.
The prevalence of the developmental disorders rose to 15 percent of U.S. children, or about 10 million, in 2006-2008, from 12.8 percent, or about 8 million, in 1997-1999, according
to the study from the Centers for Disease Control and Prevention. The research is published in the journal Pediatrics.
Researchers said the increase may be due in part to more preterm births and parents having children at older ages. They also said that improvements in screenings, diagnosis and
awareness have pushed the numbers higher. About one in six children in the U.S. now have a developmental disability, and that will likely increase demand for health and education
services, researchers said.
"Because the prevalence of some of these developmental disabilities is increasing, there's going to be an increased demand on the health system for these kind of specialized
medical services," Sheree Boulet, the study author and an epidemiologist at the Atlanta-based CDC's National Center on Birth Defects and Developmental Disabilities, said in a May 20
telephone interview.
Today's study is the first to document the prevalence of developmental disabilities in U.S. children since 1994, Boulet said.
National Health Interview
The researchers looked at data on children ages 3 to 17 years from the 1997 to 2008 National Health Interview Surveys.
The surveys are representative samples of U.S. households and asked parents to report diagnoses of ADHD, mental retardation, cerebral palsy, autism, seizures, stuttering or stammering,
moderate to profound hearing loss, blindness, learning disorders and other developmental delays.
Autism, a lifelong and disabling condition caused by abnormal brain development, had the largest increase over the study, rising nearly fourfold to 0.74 percent of children in
2006-2008 from 0.19 percent in 1997-1999, the paper showed. The disorder hinders a person's ability to communicate and engage in social interactions.
They found that the number of children with ADHD rose 33 percent during the period to 7.6 percent from 5.7 percent. The disorder was "chiefly responsible" for the higher overall
incidence of developmental disabilities in the U.S., the authors wrote. [...] [Read More]
From the Abstract... CONCLUSIONS: Developmental disabilities are common and were reported in ~1 in 6 children in the United States in 2006-2008. The number of children with select developmental disabilities (autism, attention
deficit hyperactivity disorder, and other developmental delays) has increased, requiring more health and education services. Additional study of the influence of risk-factor shifts, changes in acceptance, and benefits
of early services is needed.
[...]
A baby develops "adaptive tolerance" by suppressing inflammatory cytokines, including IL-1B and TNF-a, to make sure that T cells don’t respond to everything naturally presented to the baby as "safe".
IF a baby’s immune system is developing along a specific pathway which is designed to SHUT DOWN INFLAMMATION, as an "important developmental programme" - "beneficial to the neonate" (Chelvarajan et al., 2007) what might
be the result of tossing vaccines into a baby immediately after birth, and at regular intervals thereafter?
We know that in adults, influenza vaccines increase autoimmunity antibodies (Danzinger-Isakov et al., 2010). Does this happen in
infants and children? There is no logical reason to believe that it doesn't, but we can't be sure until such research is urgently undertaken - now that yearly influenza vaccination is forced upon babies - and
pregnant mothers.
We know that hepatitis B vaccines given to adolescents results in an increase in alloreactive cellular responses (Roddy et al., 2005), but that research hasn’t extended
to babies either. Neither have researchers looked at what happens after regular booster shots. At such a crucial non-inflammatory time, what would a neonatal immune system do with increased allo-antibodies? The fact is no one has a clue!
We know that vaccination in adolescents can result in autoimmune anti-NMDA encephalopathy (Hofmann, Baur & Schroten, 2011), but
unfortunately that research has not yet extended to babies.
We know that vaccinating mice at the critical point of immune development described by Chelvarajan, results in a skewing towards an allergic Th2
immune system (Eurekalert and Lee et al., 2008).
We also clearly know that the LONGER a parent delays giving a DPT vaccine, the less the baby's chances of developing
asthma.(McDonald et al., 2008)
A first vaccine is designed to PROVOKE inflammatory immune responses, and booster shots are designed to enhance that inflammatory process, and to keep it going for a long time.
The core of NEONATAL vaccine administration "theology" is that the earlier we vaccinate babies, the better.
The alleged "objective" of regular booster vaccinations, is that continuing to provoke the immature immune system of the baby, will result in life-long memory T-cell immunity as a
result of being repeatedly vaccinated early in life.
The other untouchable tenet of NEONATAL vaccine "theology" is that IPSO FACTO, all vaccines are safe, and do not affect, or perturb the normal functioning of the immune system,
and THAT anything that happens after a vaccine is "coincidental".
A recent study (Wherry, 2011) about "chronic" infection, has shown that
"pathogen persistence" in the body results in the body’s T-cells ["giving up" against that specific pathogen].
This is called "T-cell exhaustion". The author contrasts the very specific immune system actions against acute infection: "After infections that are cleared acutely,
highly functional memory T-cells develop...." with the across-the-board blunted action of the immune system in chronic infections. [...]
In 2003, Pihlgren et al. (2003) showed that if mammals are vaccinated too early, memory IgG responses to T-cell
dependant antigens are suppressed. In mice it took 6 – 8 weeks for the immune system to mature enough to be able
to start making long term Ig G antibodies. Pihlgren stated that in humans, the process is much longer [...]
This study showed that 16.8% of children younger than 18 years of age have lifelong conditions
arising in early childhood as a result of cognitive or physical impairment or a combination of the two.
Everywhere in the developed world, parents are starting to notice the huge numbers of children with serious chronic disorders and behavioural issues. Older teachers readily see the difference between children they
taught years ago, and children entering school in 2011.
These figures are outrageous, but are explained away by the authors as improved survival of children born preterm, or with birth defects or genetic disorders [...]
Profile of a Pertussis Vaccine Injury
Barbara Loe Fisher, President of the National Vaccine Information Center (NVIC), a non-profit charity she co-founded with parents of DPT vaccine injured children in 1982 speaks
about profile of pertussis vaccine injury in many families.
Selected Articles
The Autism Research Centre (ARC), at the University of Cambridge, England, has over 30 research scientists and support staff, drawn from a range of disciplines including
cognitive neuroscience, psychiatry, pediatrics, neonatology, genetics, and biochemistry. The ARC website is a valuable resource for articles, books and media, and various tests devised by ARC for use in the
course of their research (some of these tests are available for download). The following are selected articles.
S. J. Blakemore, T. Tavassoli, S. Calo, R. M. Thomas, C. Catmur, U. Frith and P. Haggard, (2006) Tactile sensitivity in Asperger syndrome
Brain and Cognition 61(1):5-13
S. Baron-Cohen, S. Wheelwright, C. Stott, P. Bolton and I. Goodyer, (1997) Is there a link between engineering and autism?
Autism: An International Journal of Research and Practice 1:153-163
S. Baron-Cohen, S. Wheelwright, A. Cox, G. Baird, T. Charman, J. Swettenham, A. Drew and P. Doehring, (2000) Checklist for Autism in Toddlers (CHAT)
Journal of Developmental and Learning Disorders
Dozens of genes involved in autism have been discovered by Hamilton- and Toronto-led researchers, revealing the disorder is far more complex than originally believed.
The largest study of its kind, published online yesterday by the journal Nature, reveals patients don't share common genetic variations that could be simply diagnosed with DNA testing.
Instead each patient's genes have different duplicated or deleted pieces with some occurring spontaneously and others inherited from family who inexplicably don't have autism, suggesting
other factors also play a role.
This "paradigm shift" to looking at patients as genetically unique helps explain why symptoms and severity differ so greatly that the term "autism spectrum disorders" has come into use.
"Each child with autism is unique in their clinical presentation and now we can say that they're virtually unique in their genetic make-up," said Dr. Peter Szatmari, director of
Hamilton's Offord Centre for Child Studies. [...]
Study: Functional impact of global rare copy number variation in autism spectrum disorders
Dalila Pinto, Alistair T. Pagnamenta, Lambertus Klei, Richard Anney, Daniele Merico, Regina Regan, Judith Conroy, Tiago R. Magalhaes, Catarina Correia, Brett S. Abrahams, Joana Almeida,
Elena Bacchelli, Gary D. Bader, Anthony J. Bailey, Gillian Baird, Agatino Battaglia, Tom Berney, Nadia Bolshakova, Sven Bölte, Patrick F. Bolton, Thomas Bourgeron, Sean Brennan, Jessica Brian,
Susan E. Bryson, Andrew R. Carson, et al.
Nature (2010) doi:10.1038/nature09146. [PDF]
The Work of Leila Masson, MD
Leila Masson MD is a Harvard-trained pediatrician who specializes in the biomedical treatment of autism and ADHD; she treats children with autism spectrum disorders, ADHD, behaviour problems,
allergies and eczema. Her approach is natural and holistic, looking at nutrition, nutritional deficiencies, and the environment of the child. In the following interview, she
discusses autism and her work. She talks about what autism is, what the likely causes are, what role vaccinations may play, and the various treatment modalities which have shown
the most promise. You can read more about Dr. Masson's work at her website.
21 July 2009 34:56
A CBC Ideas Feature on Autism Spectrum Disorder
Leo Kanner (1943) first described what we now call autism in a paper entitled Autistic Disturbances of Affective Contact (Nervous Child 2. 1943:217-250).
Kanner identified a pattern of behaviors he observed among a group of children in his practice, and his work remains an instructive overview of autistic symptoms. Only recently has autism been understood as the core of a
spectrum disorder, a group of disorders with similar features. Autism is now recognized in one out of 150 children. Genetic
components and environmental triggers have become the focus of investigation, as have epigenetic influences factors affecting gene expression. The following CBC Ideas feature provides an overview of this
complex disorder, with interviews and personal stories.
Source: The Dark End Of The Spectrum
CBC Radio, Ideas, with host Paul Kennedy. Episode 1 aired on 24 July 2009; episode 2 aired on 31 July 2009.
The Ideas Dark End Of The Spectrum page also provides a very useful book list and online resources.
For parents of autistic children, the realization often comes slowly. A worry, a pang, a sinking feeling when trying to play with the new baby, who seems - uninterested, even unreachable.
What could be wrong? If it is, in fact, autism, it is not the end, but the beginning of a journey.
First seen as a medical oddity, the story of autism is both fascinating and troubling. Autism was first described and named in the 1940s, in the heyday of psychoanalysis. Brilliant and
charismatic doctors concluded the disorder was caused by nurture – not nature. In short, it was the parents' fault. They were branded with the heartless label: "refrigerator mothers."
Bernice Landry explores how our understanding of autism has taken an about-face in recent years. Scientists and an army of activist parents are beginning to make up for lost time, to shine new
light on the darkest secrets of our genes.
In episode 2 we hear the story of Darius McCollum, a serial impersonator whose obsession with trains has lead him to spend much of his life in jail. Darius has been diagnosed with Aspergers
Syndrome, a version of autism.
CBC Ideas The Dark End Of The Spectrum Episode One:
CBC Ideas The Dark End Of The Spectrum Episode Two:
Abstract
Autism, a member of the pervasive developmental disorders (PDDs), has been increasing dramatically since its
description by Leo Kanner in 1943. First estimated to occur in 4 to 5 per 10,000 children, the incidence of autism
is now 1 per 110 in the United States, and 1 per 64 in the United Kingdom, with similar incidences throughout the
world. Searching information from 1943 to the present in PubMed and Ovid Medline databases, this review summarizes
results that correlate the timing of changes in incidence with environmental changes. Autism could result
from more than one cause, with different manifestations in different individuals that share common symptoms.
Documented causes of autism include genetic mutations and/or deletions, viral infections, and encephalitis following
vaccination. Therefore, autism is the result of genetic defects and/or inflammation of the brain. The inflammation
could be caused by a defective placenta, immature blood-brain barrier, the immune response of the mother
to infection while pregnant, a premature birth, encephalitis in the child after birth, or a toxic environment.
[...] Changes in rates of autism incidence
The California Department of Developmental Services conducted a study of time trends in the prevalence by age and
birth cohort of children with autism who were active clients from January 1, 1995 to March 31, 2007 (Schechter and
Grether, 2008). The data did not show any decrease in autism in California, despite the exclusion of more than trace levels
of Thimerosal from nearly all childhood vaccines by 2002. However, in 2004, inactivated influenza vaccine frequently
containing Thimerosal was newly recommended for all children 6–23-months old in the United States (Schechter and
Grether, 2008). In addition, influenza vaccination during all trimesters of pregnancy is now universally recommended in
the United States (Ayoub and Yazbak, 2006). Most inactivated influenza vaccines contain Thimerosal, despite its implication
in autism (Ayoub and Yazbak, 2006).
Data from a worldwide composite of studies show that an increase in cumulative incidence began about 1988–1990 (McDonald and Paul, 2010). The new version of the measles,
mumps, rubella vaccine (i.e., MMR II) that did not contain Thimerosal was introduced in 1979. By 1983, only the new version was available. Autism in the United States
spiked dramatically between 1983 and 1990 from 4–5/10,000 to 1/500. In 1988, two doses of MMR II were recommended to immunize those individuals who did not respond to
the first injection. A spike of incidence of autism accompanied the addition of the second dose of MMR II. Also, in 1988, MMR II was used in the United Kingdom, which
reported a dramatic increase in prevalence of autism to 1/64 (noted above). Canada, Denmark, and Japan also reported dramatic increases in prevalence of autism. It is
important to note that unlike the former MMR, the rubella component of MMR II was propagated in a human cell line derived from embryonic lung tissue (Merck and Co.,
Inc., 2010). The MMR II vaccine is contaminated with human DNA from the cell line. This human DNA could be the cause of the spikes in incidence. An additional increased
spike in incidence of autism occurred in 1995 when the chicken pox vaccine was grown in human fetal tissue (Merck and Co., Inc., 2001; Breuer, 2003). The current incidence
of autism in the United States, noted above, is approximately 1/100. The human DNA from the vaccine can be randomly inserted into the recipient's genes by homologous recombination,
a process that occurs spontaneously only within a species. Hot spots for DNA insertion are found on the X chromosome in eight autism-associated genes involved in
nerve cell synapse formation, central nervous system development, and mitochondrial function (Deisher, 2010). This could provide some explanation of why autism is predominantly
a disease of boys. Taken together, these data support the hypothesis that residual human DNA in some vaccines might cause autism. [...]
The Thimerosal Controversy
In their updated statement on Mercury and Vaccines (Thimerosal),
the U.S. Centers for Disease Control (CDC) asserts that there is "no convincing scientific evidence of harm caused by the low doses of thimerosal in vaccines,
except for minor reactions like redness and swelling at the injection site", then adds that "in July 1999,
the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed
that thimerosal should be reduced or eliminated in vaccines as a precautionary measure".
However, in July 1999, the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal should be reduced or
eliminated in vaccines as a precautionary measure.
Since 2001, with the exception of some influenza (flu) vaccines, thimerosal is not used as a preservative in routinely recommended childhood vaccines.
CDC also cites the 2004 report of the Immunization Safety Review Committee, Institute of Medicine (IOM), which "concludes that
the body of epidemiological evidence favors rejection of a causal relationship between the MMR vaccine and autism" and
"rejection of a causal relationship between thimerosal-containing vaccines and autism".
These assertions notwithstanding, there remains controversy (5.09). Almost 4,900 suits have been filed by families convinced
that vaccines have caused or contributed to neurological problems or autism in their children.3 While the specific etiology of autism is not yet known, and whereas
most accept that the numbers are on the rise, there is some debate as to whether the increase in diagnoses is (1) the result of an environmental cause such as thimerosal-containing vaccines,
the frequency of vaccinations in childhood, exposure to hazardous air pollutants (HAPs) or other chemical toxins, or (2) an artifact of greater surveillance and broader diagnostic frameworks
"autism" → "autism spectrum disorder" (see, e.g., The Increase in Autism Diagnoses: Two Hypotheses, Steven
Novella, Science-Based Medicine (16.04.08).
As toxicologist Mona Sethi Gupta (2008) writes, however, even in the latter case, "it is becoming increasingly apparent that environmental
neurotoxins in combination with genetic predispositions could also create adverse gene-environment interactions". 10
The concensus, at this point, is that thimerosal-containing vaccines are not the causative factor.
"It's not a medical or scientific controversy; it's a cultural controversy," says Paul Orfitt, MD, chief of the Section of Infectious Diseases at Children's Hospital of Philadelphia. "The
science has exonerated vaccines. First, there was the hypothesis that the measles-mumps-rubella vaccine caused autism. That was tested in the only way you can test it, which is to look at
hundreds of thousands of children who did or didn't receive that vaccine to see whether the risk of autism was greater in the vaccinated group. It wasn't again and again and again. There have
been 12 studies that have looked at that."
OBJECTIVE Exposure to thimerosal, a mercury-containing preservative that is used in vaccines and immunoglobulin preparations, has been hypothesized to be
associated with increased risk of autism spectrum disorder (ASD). This study was designed to examine relationships between prenatal and
infant ethylmercury exposure from thimerosal-containing vaccines and/or immunoglobulin preparations and ASD and 2 ASD subcategories:
autistic disorder (AD) and ASD with regression.
METHODS A case-control study was conducted in 3 managed care organizations (MCOs) of 256 children with ASD and 752 controls matched by birth year, gender, and MCO. ASD
diagnoses were validated through standardized in-person evaluations. Exposure to thimerosal in vaccines and immunoglobulin preparations was determined from electronic immunization registries, medical
charts, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We used conditional logistic regression to assess associations between ASD,
AD, and ASD with regression and exposure to ethylmercury during prenatal, birth-to-1 month, birth-to-7-month, and birth-to-20-month periods.
RESULTS There were no findings of increased risk for any of the 3 ASD outcomes. The adjusted odds ratios (95% confidence intervals) for ASD associated with a 2-SD
increase in ethylmercury exposure were 1.12 (0.83–1.51) for prenatal exposure, 0.88 (0.62–1.26) for exposure from birth to 1 month, 0.60 (0.36–0.99) for exposure from birth to 7 months, and 0.60
(0.32–0.97) for exposure from birth to 20 months.
CONCLUSIONS In our study of MCO members, prenatal and early-life exposure to ethylmercury from thimerosal-containing vaccines and immunoglobulin preparations was
not related to increased risk of ASDs.
Early Thimerosal Exposure and Neuropsychological Outcomes at 7 to 10 Years
Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team.
N Engl J Med. 2007 Sep 27;357(13):1281-92.
Conclusions/Significance
This study provides strong evidence against association of autism with persistent MV RNA in the GI tract or MMR exposure. Autism
with GI disturbances is associated with elevated rates of regression in language or other skills and may represent an endophenotype
distinct from other ASD.
[...] But the Autism Society of America cautioned that the cause of autism is complex and more research is needed to
fully understand the role, if any, of the vaccine.
Another autism advocacy group, the National Autism Association (NAA), said the study is flawed.
"This new study does nothing to resolve the controversy whether MMR vaccine has contributed to the autism epidemic,"
said a press release from the group.
Wendy Fournier, an NAA spokeswoman, told CNN Thursday that the new study raises more questions than answers and should
have looked at more children who developed autism and GI problems after they received the vaccine.
Only 5 children in the Columbia study were vaccinated before they developed GI symptoms and autism.
According to the CDC, measles is a highly infectious disease that can result in severe, sometimes permanent, complications --
even death. Measles remains widespread in most countries, but widespread vaccination has limited its spread in the United States.
Some parents, familiar with the Wakefield theory's putative link between vaccine and autism, have chosen not to vaccinate their
children. Last month, the CDC reported 131 cases of measles in the United States in the first seven months of the year, of which
112 were either among unvaccinated children or children whose vaccination status was unknown [...]
Wakefield, Brian Deer's allegations, the BMJ, and vaccinations
In February 1998, the Lancet medical journal triggered a global alarm with research proposing a link between
the measles, mumps and rubella triple vaccine and autism. The researchers' leader, Andrew Wakefield called for the vaccine to be
"suspended". Six years later, Brian Deer investigated for The Sunday Times of London and Channel 4 television.
On January 5, 2011, the British Medical Journal accused Dr. Andrew Wakefield of committing "an elaborate fraud" in the controversial 1998 Lancet report about 12 children who developed
bowel disease and regressed after receiving the MMR shot. The cover article by journalist Brian Deer focused on "the bogus
data behind claims that launched a worldwide scare over the measles, mumps, and rubella vaccine."
Deer identified and interviewed parents of some of the children in the anonymous Lancet case series, describing what he said were significant disparities. "I traveled to the family home, 80
miles northeast of London, to hear about child 2 from his mother," Deer wrote of one interview. The child had severe autism and gut problems that she blamed on the MMR.
What Deer did not say in the BMJ article is that he had lied to the mother about his identity, claiming to be someone named "Brian Lawrence" (his middle name). Deer had written a number of critical
articles about parents' claims of vaccine injury, and if he gave his real name, he doubtless feared, Child 2's mother would not agree to talk to him. Once she checked his blog, she would be more likely to
kick him out of the family home than sit still for what turned into a six-hour inquisition.
He even created a fake e-mail address for his fake identity, and he used it to communicate with her: lawrence_b_st@yahoo.com.
Why did the highly respected British Medical Journal sanction such deceit involving the mother of a child who, whatever the cause, was severely disabled? When the interview took place in November 2003,
more than seven years before the BMJ article, Deer was not working for the journal. He was on assignment for The Sunday Times of London.
The Sunday Times is owned by Rupert Murdoch, part of the News International division that has come under a Watergate-size cloud in England for its newsgathering tactics – fraudulently obtaining confidential
information, bribing police, hacking 9,000 phone numbers, gaining access to bank accounts, and using large financial settlements to keep some victims quiet.
The BMJ article, titled "How the Case Against the MMR Vaccine Was Fixed," has its roots in the Sunday Times. It is remarkably similar to one Deer wrote for the Sunday Times two years earlier, in February 2009. That article was titled MMR Doctor Andrew Wakefield Fixed Data on Autism and it cited much the same data and mentioned many of the same people featured in the BMJ article.
The BMJ imprimatur gave Deer – as well as the British Medical Association, which publishes the journal -- a "peer-reviewed" platform from which the story was broadcast far and wide, as conclusive proof of
fraud. The BMJ dressed up its presentation with footnotes, charts, editorials, commentary and what it called "editorial checking."
But clearly, the crux of the article came from reporting Deer did while affiliated with the Sunday Times. Along with evidence presented at a General Medical Council hearing, Deer wrote in the Sunday Times,
he relied on "unprecedented access to medical records, a mass of confidential documents and cooperation from parents during an investigation by this newspaper." His work, he said, exposed the "selective reporting and
changes to findings that allowed a link between MMR and autism to be asserted."
Deer did not identify Child 2 or his mother in either the Sunday Times or the BMJ – he didn't need to. He had posted their names on his blog (subsequently removed); what's more, the names were
known because the mother had spoken out on the researchers' behalf and was a claimant in a failed legal case over the vaccine. (Deer has said any allegation he "placed confidential information on my website" is false.)
False pretenses and confidentiality aside, the BMJ's ethics code bars the use of anyone's medical information without written permission -- even when the subject is anonymous.
"Any article that contains personalmedicalinformation about an identifiablelivingindividual requires the patient's explicit consent before we can publish it,"
according to the policy (italics in original). "We will need the patient to sign our
consent form, which requires the patient to have read the article."
If she had done so, the journal would have gotten an earful about "Brian Lawrence," Brian Deer and her subsequent dealings with the Sunday Times. That is the subject of our next article.
"We have 16 studies already that clearly state that vaccines do not cause autism." Amy Pisani, Executive Director, Every Child By Two
"16 studies have shown no causal association between vaccines and autism, and these studies carry weight in the scientific industry." Dr. Nancy Snyderman, NBC Today Show Medical Editor
"The science is largely complete. Ten epidemiological studies have shown MMR vaccine doesn't cause autism; six have shown thimerosal doesn't cause autism." Dr. Paul Offit, "Autism's False Prophets"
----------------------------
A NOTE FROM SAFEMINDS:
There are 16 epidemiological studies here on MMR vaccines, thimerosal and autism. These studies represent the most often cited papers by scientists, public health officials
and members of the media when trying to refute any evidence of an association between vaccinations and autism.
There are serious methodological limitations, design flaws, conflicts of interest or other problems related to each of these 16 studies. These flaws have been pointed out by
government officials, other researchers, medical review panels and even the authors of the studies themselves. Taken together, the limitations of these studies make it impossible
to conclude that thimerosal and MMR vaccines are not associated with autism.
One additional study on autism and thimerosal was published in September 201[0] while this paper was in completed draft form. This study's methods produced a result that
demonstrated that thimerosal exposure was protective against autism. Further analysis of this study is forthcoming but not included here.
PART 1: MAJOR GAPS IN KNOWLEDGE
Conventional wisdom holds that the autism-vaccine question has been "asked and answered," and that at least 16 large, epidemiological studies have thoroughly addressed
and debunked any hypothesis that childhood vaccination is associated with an increased risk of autism spectrum disorder.
But there are numerous critical flaws in such an oversimplified generalization, and they are rarely given close examination by public health experts or members of the media.
It is particularly discouraging that members of the scientific community are so willing to dismiss a hypothesis that has yet to be fully tested. Overconfident pronouncements such
as those found in the quotes above do nothing to advance either the cause of science or our understanding of the complex issues involved. They are, instead, the product of
misunderstanding and wishful thinking, brought about by the overzealous drive to ‘disprove' an unpopular and possibly disquieting theory.
Respected medical opinion-makers such as Dr. Snyderman and Dr. Offit mislead the public when they categorically state that there is "no link" between vaccines and autism.
Their misguided conclusions are based on incomplete knowledge and misinterpretations, and likely to be influenced by personal and professional conflicts of interest; conflicts
illustrated by their intimate and lucrative financial bonds with GlaxoSmithKline (Snyderman) and Merck (Offit), - two of the world's leading vaccine manufacturers.
There is a host of reasons why the cavalier dismissal, by scientists and physicians, of any possible vaccine-autism association is premature, shortsighted, and wrong.
But first, some clarification about terminology. Frequently, a counter-claim to those made by the likes of Snyderman and Offit is that ‘epidemiological' studies cannot be used to
establish or refute, causality.
In the following analysis, we review and critique the analytical epidemiology studies most commonly cited as evidence against the "autism-vaccine" hypothesis. We must
make clear at the outset, however, that this critique addresses only a fraction of the "autism-vaccine" connection. In fact, the studies reviewed here have explored only two
discrete (and frequently confused) exposures: one vaccine, the measles-mumps-rubella vaccine (MMR) and one vaccine ingredient, the ethyl mercury based preservative,
thimerosal. None of these studies have addressed possible interactions between the two exposures or the effect of these exposures in the larger context of an expanded childhood
immunization program. No study has yet been conducted comparing total health outcomes in vaccinated human children with unvaccinated children. As a result, the gap
between the study sample reviewed here and a full examination of vaccination exposure and autism risk is remains quite large and largely unexamined.
However, with respect the body of analytical epidemiology on MMR and thimerosal, we draw the following conclusion. The evidence in the studies that are most often claimed to
provide conclusive proof dismissing a connection between these exposure and autism do not stand up to close scrutiny. Many of them do not provide evidence one way or another
with respect to the hypothesis; some of them provide evidence actually supporting an exposure effect; others are too poorly designed to extract any reasonable conclusions; and
in some instance the data have been manipulated in ways that border on misconduct.
In short, although the question of the connection between autism and vaccines has been asked, we have yet to see any reliable and informative answers. [...]
The topics of vaccines and vaccine safety spark emotional outbursts at scientific meetings and family dinner tables alike. But many of these debates are remarkably fact-free. Surprisingly few people — not just
concerned parents but also doctors, policymakers and even immunization experts — can answer this seemingly simple question: How many immunizations does the federal government recommend for every child during the
first two years of life?
The answer is important because most states, including Maryland, faithfully follow the recommendations of the federal Centers for Disease Control and Prevention, codifying CDC guidelines into requirements for children
to enroll in school, kindergarten, preschool and child care.
A new Journal of Toxicology and Environmental Health study reports that the higher the proportion of infants and toddlers receiving recommended vaccines, the higher the state's rate of children diagnosed with autism
or speech-language problems just a few years later. This analysis is sure to rekindle the debate about vaccine safety.
For that conversation to produce useful results, we must start by defining terms. A "dose of vaccine" refers to each vaccine or antigen given to increase immunity against one specific disease. For chicken pox, a child
receives one dose of vaccine through one shot.
By contrast, an "immunization event" refers to each separate administration of a vaccine or bundle of vaccines — through a shot, orally, or nasally. The MMR shot for mumps, measles and rubella involves three doses of
vaccine but is one immunization event.
The critical number is how many doses of vaccine a child receives. Why? If a vaccine is strong enough to confer immunity against a disease, it is important enough to count separately.
Clear definitions, analysis of CDC's "General Recommendations on Immunization," and confirmation by Dr. Andrew Kroger, lead author of the definitive report on these recommendations, produce the answer to the
not-so-simple-after-all question posed above.
In all, the federal government recommends 36 doses of vaccine, addressing 14 different diseases, for every U.S. child under age 2. An on-schedule child will receive a dose of vaccine for hepatitis B at birth, eight
doses of various vaccines at 2 months, seven additional doses at 4 months, and four to seven more doses at 6 months.
Infants and toddlers receive these vaccine doses through 26 separate immunization events — mostly shots. If a child misses vaccinations because of illness or scheduling problems, following CDC's catch-up schedule
usually results in extra doses at a later date.
The federally recommended doses of vaccine for every child during the first two years of life are: three doses each for hepatitis B, polio, flu, and HIB (12 doses in all); two doses each for hepatitis A and rotavirus; four
doses for pneumococcal infections; one dose for chicken pox; three doses through the combination MMR vaccine for measles, mumps and rubella; and 12 doses through four separate administrations of the combination DTaP
vaccine for diphtheria, tetanus and pertussis (whooping cough).
Some infants and toddlers receive still more doses of vaccine — if they switch to pediatricians who use different "combined" vaccines, if they are at high risk for certain diseases, if lost or incomplete
records lead to duplicate immunizations, and depending on the time of year they were born (for flu shots) or the brand of vaccine used.
While testing is routine for individual vaccines as they are licensed, research on the both short- and long-term effects of multiple doses of vaccine administered to very young children during the critical birth-to-2
developmental window is sparse to nonexistent.
In addition to the number of doses, vaccine ingredients can be problematic, especially for susceptible subgroups. First are adjuvants, substances added to boost effectiveness and allow smaller doses of vaccine
antigen to be used. The most common adjuvant is aluminum, which is found in vaccines for hepatitis and diphtheria-pertussis-tetanus.
Second are preservatives — such as thimerosal, which is 49.6 percent mercury. Thimerosal is still contained in many flu shots, although it was, except for trace amounts, removed from other child vaccines a decade ago.
Many child vaccines (including those for diphtheria-pertussis-tetanus, HIB, and hepatitis) contain formaldehyde, which was just added to the government's list of known human carcinogens.
Third are ingredients to which some people have severe allergies: stabilizers such as gelatin, and eggs or other proteins that are used to prepare vaccines for flu, MMR, and other immunizations.
The ongoing debate about vaccines and their safety needs to incorporate these basic facts as our country seeks to answer the critical Goldilocks question: Too many? Too few? Or just right?
The study evaluated possible associations between neurodevelopmental disorders (NDs) and exposure to mercury (Hg) from
Thimerosal-containing vaccines (TCVs) by examining the automated Vaccine Safety Datalink (VSD). A total of 278,624 subjects
were identified in birth cohorts from 1990-1996 that had received their first oral polio vaccination by 3 months of age
in the VSD. The birth cohort prevalence rate of medically diagnosed International Classification of Disease, 9th revision
(ICD-9) specific NDs and control outcomes were calculated. Exposures to Hg from TCVs were calculated by birth cohort for
specific exposure windows from birth-7 months and birth-13 months of age. Poisson regression analysis was used to model
the association between the prevalence of outcomes and Hg doses from TCVs. Consistent significantly increased rate ratios
were observed for autism, autism spectrum disorders, tics, attention deficit disorder, and emotional disturbances with Hg
exposure from TCVs. By contrast, none of the control outcomes had significantly increased rate ratios with Hg exposure
from TCVs. Routine childhood vaccination should be continued to help reduce the morbidity and mortality associated with
infectious diseases, but efforts should be undertaken to remove Hg from vaccines. Additional studies should be conducted
to further evaluate the relationship between Hg exposure and NDs.
March 6, 2008 -- Federal officials say a Georgia girl is entitled to compensation from a federal vaccine injury fund because
she developed autism-like symptoms after receiving childhood vaccines in 2000.
Hannah's father, Jon, tells WebMD he was not surprised
by the compensation decision.
"When you are talking about the courtroom versus science,
the burden of proof is different," Poling says. "(But) we showed there was a plausible mechanism. We showed that an injury occurred
shortly after her vaccination. Her growth curve went flat for months."
The government has not said that childhood vaccines cause autism; rather, officials conclude that the vaccines given to the girl
in 2000 aggravated a pre-existing condition -- a mitochondrial disorder -- that then manifested as a regressive neurological
disease with some symptoms of autism spectrum disorder. [...] [Read More]
[...] Overall, nearly 4,900 families have filed claims with the U.S. Court of Claims alleging that vaccines caused autism and
other neurological problems in their children. Lawyers for the families are presenting three different theories of how vaccines
caused autism. The theory at issue Monday was whether vaccines containing the preservative thimerosal caused autism.
Lynn Ricciardella, a Justice Department lawyer, said that theory has not moved beyond the realm of speculation. She said that the Institute of Medicine and the Centers for Disease Control
and Prevention have rejected any link between thimerosal and autism. [...]
Recommended Immunization Schedule for Persons Aged 0–6 Years US • 2008
Department of Health and Human Services, Centers for Disease Control and Prevention.
The Recommended Immunization Schedules for Persons Aged 0–18 Years are approved by the Advisory Committee on Immunization Practices (www.cdc.gov/vaccines/recs/acip),
the American Academy of Pediatrics (http://www.aap.org), and the American Academy of Family Physicians (http://www.aafp.org).
[...] As more and more vaccines were added to the mandatory schedule of vaccines for children, the dose of the mercury-based
preservative thimerosal rose, so that the cumulative dose injected into babies exceeded the toxic threshold set by many
government agencies. Mercury is known to damage nerve cells in very low concentrations.
The concern about vaccines may actually be underrated, as it is generally acknowledged that the voluntary reporting of
such disorders has resulted in vast underreporting of new cases. For example, the Iowa state legislature banned thimerosal
from all vaccines administered there after it documented a 700-fold increase in that state alone. California followed
suit, and 32 states are considering doing so.
Up until about 1989 pre-school children got only 3 vaccines (polio, DPT, MMR). By 1999 the CDC recommended a total of
22 vaccines to be given before children reach the 1st grade, including Hepatitis B, which is given to newborns within
the first 24 hours of birth. Many of these vaccines contained mercury. In the 1990s approximately 40 million children
were injected with mercury-containing vaccines.
The cumulative amount of mercury being given to children in this number of vaccines would be an amount 187 times the
EPA daily exposure limit.
Between 1989 and 2003, there has been an explosion of autism. The incidence of autism (and other related disorders)
went from about 1 in 2,500 children to 1 in every 166. Currently there are more than a half million children in the U.S.
that have autism. This disorder has devastated families.
In 1999, on the recommendation of the American Academy of Pediatrics and U.S. Public Health Service, thimerosal was
removed from most childhood vaccines as a "precautionary" measure - i.e. without admitting to any causal link between
thimerosal and autism.
The Geiers conclude that mercury continues to be a concern, as it is still added to some of the most commonly-used vaccines,
such as those for flu:
"Despite its removal from many childhood vaccines, thimerosal is still routinely added to some formulations of influenza
vaccine administered to U.S. infants, as well as to several other vaccines (e.g. tetanus-diphtheria and monovalent tetanus)
administered to older children and adults. In 2004, the Institute of Medicine (IOM) of the U.S. National Academy of Sciences
(NAS) retreated from the stated 1999 goal of the AAP and the PHS to remove thimerosal from U.S. vaccines as soon as possible.
As a result, assessing the safety of TCVs [thimerosal-containing vaccines] is a matter of significant importance."
[...] In 1999, professional groups called
for thimerosal to be removed from vaccines as a precaution.
Unfortunately, the precipitous removal of thimerosal from
all but some multidose preparations of influenza vaccine
scared some parents. Clinicians were also confused by the
recommendation.
Since the removal of thimerosal, six studies have been
performed to determine whether thimerosal causes autism.
Again, hundreds of thousands of children who received
thimerosal-containing vaccines were compared to hundreds
of thousands of children who received the same vaccines free
of thimerosal. The results were clear: The risk of autism was
the same in both groups. [...]
According to Dr. Hugh Fundenburg, one of the most quoted biologists of our time, with nearly 850 papers in peer review journals,
it isn't just children who are at risk. Fundenburg writes that "if an adult receives too many consecutive flu shots containing
thimerosal, his or her chance of developing Alzheimer's disease is ten times greater than if he or she had one, two, or no shots."
When asked why this was so, Dr. Fundenburg stated that "the gradual mercury and aluminum buildup in the brain causes eventual
cognitive dysfunction."
Schwartz-Nobel is an award-winning investigate journalist. In her chapter entitled The Autism Epidemic, the
author presents a damning indictment of the Bush administration, the CDC, and behind-the-scenes politics regarding the thimerosal
controversy (pp.85-101). Cf. below: CDC, FDA and SafeMinds.org. The CDC makes the following
statement in its Inactivated Influenza Vaccine: What You Need To Know 2007-2008 advisory:
Some inactivated influenza vaccine contains thimerosal, a preservative that contains mercury. Some people believe
thimerosal may be related to developmental problems in children. In 2004 the Institute of Medicine published a
report concluding that, based on scientific studies, there is no evidence of such a relationship. If you are concerned
about thimerosal, ask your doctor about thimerosal-free influenza vaccine.
Thimerosal is a mercury-based preservative developed in the 1930s that has been used in as many as 50 vaccines. In the 1982 Federal Register,
an expert panel at the FDA reviewed thimerosal and found that it was toxic, caused cell death and
called for its removal in over the counter products
In 2001 the Institute of Medicine, in reviewing the
use of thimerosal in vaccines, recommended that "government agencies give full consideration to
removing thimerosal from all vaccines administered to infants, children or pregnant women."
You can request thimerosal-free vaccines from your healthcare provider. SafeMinds recommends contacting your health care provider well in
advance to ask specifically for a thimerosal-free vaccine.
The Coalition for SafeMinds (Sensible Action for Ending Mercury-Induced Neurological
Disorders) is a private nonprofit organization founded to investigate and raise awareness
of the risks to infants and children of exposure to mercury from medical products,
including thimerosal in vaccines. Since its inception in 2000, SafeMinds has
sponsored almost one million dollars in research related specifically to mercury and
adverse neurological outcomes, including autism. This level of financial commitment
establishes SafeMinds as the largest private non-profit organization funding mercury and
autism related research. For more information please visit safeminds.org
There is little chance for a six month old to be exposed to mercury through vaccination. Most vaccines licensed in Canada
do not contain thimerosal. Since 1994, all routine childhood vaccines, with the exception of the flu vaccine, administered
in Canada have not contained thimerosal. Thimerosal is not added to single dose vaccines.
In Canada, vaccines to prevent the following diseases are used for routine immunization of children and do not contain thimerosal:
diphtheria
tetanus (lockjaw)
pertussis (whooping cough)
polio
rubella (German measles)
measles (red measles)
mumps
hepatitis B (available free to children only in some provinces and territories)
Haemophilus influenzae type b disease
For immunization of infants against hepatitis B, parents or guardians in some provinces and territories have
the choice of a thimerosal-free vaccine.
[...] Autism is a neurodevelopmental disorder characterized by impaired social interaction as well as verbal and non-verbal
communication. There are various degrees of severity involved in this disorder. Therefore, this condition is commonly
referred to as "autism spectrum disorders" or ASD which include autism, Asperger's syndrome, pervasive developmental
disorders not otherwise specified (PDD-NOS) and high-functioning autism. Statistics based on data gathered in 2002
indicates that more than 550,000 children are affected by varying degrees of autism spectrum disorders (ASD). In fact,
it has been reported that autism is the fastest growing developmental disability, increasing at a rate of 10 to 17 percent
annually according to the Autism Society of America. While improved diagnostic measures may contribute to the perceived
increase in the number of cases, it is becoming increasingly apparent that environmental neurotoxins in combination with
genetic predispositions could also create adverse gene-environment interactions.
Surveys conducted in California indicate an almost 210% increase in the number of cases of autism in children over the past
10 years. There is increasing concern that certain chemicals (such as mercury, halogenated aromatics and pesticides) and biotic
factors (such as vaccine antigens) may act synergistically to alter certain susceptibility or genetic risk factors to result
in ASD. The UC Davis Center for Children's Environmental Health has established the first large scale epidemiological study
to investigate the underlying causes of autism. The UC Davis researchers at the Children's center have suggested an association
between thimerosal (ethyl mercury) and immune system dysfunction in mice. In a recent study, Windham et. al. (2006) explored
the possible association between ASD and environmental exposures to hazardous air pollutants in the San Francisco Bay area. Based
on the data from the study, the authors suggested that living in areas with higher ambient levels of HAPs [Hazardous Air Pollutants], especially metals and
chlorinated solvents, during pregnancy or early childhood could be associated with a moderately increased risk of autism. This
study highlighted the need for more complex etiologic studies combining exposure to multiple compounds by various pathways with
genetic information to further understand the contribution of environmental exposures to the development of autism. [...] [Read More]
[...] Grandjean suspects there may be a silent pandemic of brain development disorders which start even before babies leave the womb.
If little is known about many chemicals, perhaps their effects are even worse than we currently suspect, say the scientists. The
researchers said that more stringent controls on their limits should be imposed until we know more about their effects on the
developing brain. Pregnant women and young children are uniquely sensitive to chemicals, say the researchers - limits should take
this into account.
The report states that 1-in-6 children has a developmental disability, which mostly affect the nervous system. The prevention of
neurodevelopmental disabilities is hampered by the great gaps in testing chemicals for developmental neurotoxicity and the high
level of proof needed for regulation.
Industrial chemicals we do know about, such as lead, are known to cause fetal brain injury at significantly lower doses than
for adults. Consequently, we have lowered the lead content of gas (petrol). Even so, successful campaigns came about after long
delays, say Grandjean and co-author Dr. Philip Landrigan, Department of Community Medicine, Mount Sinai School of Medicine, NY, USA.
There are thousands of chemicals which are registered for commercial use - in 1981 the EU had 100,000 of them registered, while
the USA had 80,000. Under half of all chemicals most commonly used in commerce have had token lab tests. The researchers fear
that the few chemicals we do know about, regarding harm to brain development, could be just the tip of a gigantic iceberg.
Just as scientists raced to define the human genome, the Human Toxome Project (HTP) at Environmental Working Group
is working to define the human toxome-the full scope of industrial pollution in humanity. HTP scientists use cutting edge
biomonitoring techniques to test for industrial chemicals like bisphenol A and perchlorate that enter the body through pollution
or even as ingredients in everyday consumer products.
CHICAGO -- A new analysis of U.S. health data links children's attention-deficit disorder with exposure to common pesticides used on fruits and vegetables.
While the study couldn't prove that pesticides used in agriculture contribute to childhood learning problems, experts said the research is persuasive. [...]
Children may be especially prone to the health risks of pesticides because they're still growing and they may consume more pesticide residue than adults relative to their body weight.
In the body, pesticides break down into compounds that can be measured in urine. Almost universally, the study found detectable levels: The compounds turned up in the urine of 94 percent
of the children.
The kids with higher levels had increased chances of having ADHD, attention-deficit hyperactivity disorder, a common problem that causes students to have trouble in school. The
findings were published Monday in Pediatrics.
The children may have eaten food treated with pesticides, breathed it in the air or swallowed it in their drinking water. The study didn't determine how they were exposed. Experts
said it's likely children who don't live near farms are exposed through what they eat.
"Exposure is practically ubiquitous. We're all exposed," said lead author Maryse Bouchard of the University of Montreal.
She said people can limit their exposure by eating organic produce. Frozen blueberries, strawberries and celery had more pesticide residue than other foods in one government report.
A 2008 Emory University study found that in children who switched to organically grown fruits and vegetables, urine levels of pesticide compounds dropped to undetectable or close
to undetectable levels. [...]
WHAT'S KNOWN ON THIS SUBJECT:
Exposure to organophos- phates has been associated with adverse effects on
neurodevelopment, such as behavioral problems and lower
cognitive function. Studies have focused, however, on populations
with high levels of exposure, relative to the general population.
WHAT THIS STUDY ADDS:
We conducted a study with 1139 children 8 to 15 years of age, representative of the US population.
The findings showed that children with higher urinary levels of organophosphate metabolites were more likely to meet the
diagnostic criteria for ADHD.
New research from Cold Spring Harbor Laboratory (CSHL) might help explain how a gene mutation found in some autistic individuals leads to difficulties in processing auditory cues and paying spatial attention to sound...
New research on autism in adults has shown that adults with a more severe learning disability have a greater likelihood of having autism. This group, mostly living in private households, was previously 'invisible' in estimates of autism...
A team led by researchers at the University of California, San Diego School of Medicine reports that newly discovered mutations in an evolved assembly of genes cause Joubert syndrome, a form of syndromic autism. The findings are published in the online issue of Science Express...
A hallmark of the individual is the cultivation of personal interests, but for some people, their intellectual pursuits might actually be genetically predetermined. Survey results published by Princeton University researchers in the journal PLoS ONE suggest that a family history of psychiatric conditions such as autism and depression could influence the subjects a person finds engaging...
A recent study that took place at the Centre for Brain and Cognitive Development, Birkbeck, University of London, and was published in the January edition of Current Biology, states that detecting autism symptoms in babies as young as 6 months old can help to determine how the autism will develop later in the child's life...
Children with autism spectrum disorders (ASD) tend to be fascinated by screen-based technology. A new study by a University of Missouri researcher found that adolescents with autism spend the majority of their free time using non-social media, including television and video-games...
Teaching children with autism to 'talk things through in their head' may help them to solve complex day-to-day tasks, which could increase the chances of independent, flexible living later in life, according to new research...
Getting an autism diagnosis could be more difficult in 2013 when a revised diagnostic definition goes into effect. The proposed changes may affect the proportion of individuals who qualify for a diagnosis of autism spectrum disorder, according to preliminary data presented by Yale School of Medicine researchers at a meeting of the Icelandic Medical Association...
Autism Spectrum Disorders (ASD) come with several neurodevelopmental signs and symptoms which overlap other conditions - it is possible that some early ASD diagnoses are wrong, especially among children who no longer meet the criteria for ASD as they get older, researchers from the Johns Hopkins Bloomberg School of Public Health wrote in the journal Pediatrics...
Although the genetic basis of autism is now well established, a growing body of research also suggests that environmental factors may play a role in this serious developmental disorder affecting nearly one in 100 children. Using a unique study design, a new study suggests that low birth weight is an important environmental factor contributing to the risk of autism spectrum disorder (ASD)...
Eighty-five percent of children's learning is related to vision. Yet in the U.S., 80 percent of children have never had an eye exam or any vision screening before kindergarten, statistics say. When they do, the vision screenings they typically receive can detect only one or two conditions...
Kids Clear™ Detoxifying Clay Baths
Kids Chelat™ Liquid Chelation Drops
Alternative health information and effective natural products for detoxification, pH balance, proper supplementation and cellular renewal.
The ability to detect autism in children as young as nine months of age has sparked immediate and widespread interest
in the media. The Early Autism Study, led by Mel Rutherford,
associate professor of psychology in the Faculty of Science's Department of Psychology, Neuroscience & Behaviour, has
been using eye tracker technology that measures eye direction while the babies look at faces, eyes and bouncing balls
on a computer screen.
Forty-five babies were tested in the study at three, six, nine and 12 months of age. The babies were shown four sets of pictures --
a clear face beside a scrambled face, a direct gaze beside an indirect gaze, bouncing balls interacting with each other versus
balls not interacting and a face on its own to determine whether the baby would look at the eyes or the mouth. Based on the trials,
a child with autistic leanings is more likely to look at the scrambled face, the indirect gaze, the independent balls, and the mouth.
"In each case, the typically developing child is attracted to the social stimuli," Rutherford explained.[1]
[...] "What's important about this study is that now we can distinguish between a group of siblings with autism from a group with no
autism -- at nine months and 12 months," says Rutherford. "I can do this in 10 minutes, and it is objective, meaning that the
only measure is eye direction; it's not influenced by a clinician's report or by intuition. Nobody's been able to distinguish
between these groups at so early an age." [Read More]
Intraspec.ca : Tools for Personal Development Readings, writings and research on matters of health and well-being. Richard Dagan. 2002-2012. A not-for-profit site.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Exceptions, where copyright resides with the original author or current holder thereof, include all excerpted text and third-party images provided herein. All such material is presented in accord with
fair dealing and
fair use, fully cited, and hyperlinked to source whenever possible.
Logos and trademarks are the property of their respective owners. Country flags courtesy ConveyThis.
Translation service courtesy Google.com. For privacy and legal notices, see
About.